# Arbutus Biopharma Corp: Form 8-K, filed Mar 14, 2023

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2023-03-14
- Accepted by EDGAR: Mar 14, 2023, 16:06 ET
- Period: 2023-03-14
- Accession: 0001171843-23-001679
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184323001679/f8k_031423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184323001679/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184323001679/f8k_031423.htm

Filed Mar 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-001679. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.